CIK: 1168060 - Address: C/O Aerovate Therapeutics, Inc., 930 Winter Street, Suite M-500, Waltham, MA 02451
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/7/24 18:00
2/5/24
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCM.d92.02052D
2/7/24 18:00
2/5/24
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCS.d-8017.450-5-742D
1/8/24 18:00
1/5/24
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCM.d92.02052D
1/8/24 18:00
1/5/24
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCS.d-8819.160-5-742D
12/7/23 18:00
12/5/23
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCM.d92.02052D
12/7/23 18:00
12/5/23
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCS.d-7516.300-5-742D
11/27/23 18:00
11/22/23
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCM.d282.020142D
11/27/23 18:00
11/22/23
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCS.d-20715.000-14-902D
7/7/23 18:00
7/5/23
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCM.d52.02022D
7/7/23 18:00
7/5/23
AVTEAerovate Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNiven RalphMAOCHIEF SCS.d-3917.300-2-582D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact